Subscription Center
Aug 18, 2008
On Friday, the U.S. Food and Drug Administration approved the first-ever treatment for Huntington's disease—the crippling illness that killed folksinger Woody Guthrie and that plagues 30,000 Americans.
Tetrabenazine, known commercially as Xenazine, was originally developed in the 1950s to treat symptoms of psychosis. It's not a cure-all for sufferers of the disease. Rather, it addresses a primary symptom of Huntington's—which is seen in 90 percent of patients: involuntary, spastic movements. According to a 2006 study, researchers at the University of Rochester Medical Center were able to reduce these movements in 54 patients by an average of 25 percent.
See what we're tweeting about
michaelshermer Did you know that "SM performances are deeply tied to capitalist cultural formations"? Or that BDSM is "a paradigmatic consumer sexuality"? michaelshermer PoMo nonsense: "These binaries rely on the social construction of risk." "In what follows, I unfold the thickness of such loadedness." michaelshermer Camille Paglia smack down of post modernism. PoMo: "Late capitalism itself produces the transgressiveness of sex." http://t.co/M6dZMs1Px1
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Deadline: Jul 30 2013
Reward: $100,000 USD
The Seeker desires a method for producing pseudoephedrine products in such a way that it will be extremely difficult for clandestine che
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
